TNFα Blockade Inhibits Both Initial and Continued Control of Pulmonary Coccidioides
Open Access
- 31 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11, 796114
Abstract
Tumor necrosis factor alpha (TNFα) is a pluripotent cytokine that is important in many infections, though its role in Coccidioides infection remains poorly understood. The need to understand TNFα in Coccidioides infection has increased recently with the widespread use of TNFα inhibitors for a wide variety of autoimmune conditions. Here, we couple the newly developed Coccidioides infection model using strain Cp1038 and C57BL/6 × DBA/2J F1 (B6D2F1) mice. B6D2F1 mice develop long-lasting control of Cp1038. Treatment of B6D2F1 mice with anti-TNFα antibodies permits significant fungal proliferation and death. Additionally, we show that antibody treatment limited to the first 2 weeks of infection was sufficient to induce this same loss of fungal control. Importantly, anti-TNFα antibody treatment initiated after fungal control leads to a loss of host control. These results highlight the importance of TNFα in both the initial control of murine Coccidioides and ongoing suppression of the fungal disease.Keywords
Funding Information
- National Institutes of Health
This publication has 19 references indexed in Scilit:
- A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal InfectionInfection and Immunity, 2016
- New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysisAutoimmunity Reviews, 2015
- Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of CoccidioidomycosisClinical Microbiology Reviews, 2013
- Management of coccidioidomycosis in patients receiving biologic response modifiers or disease‐modifying antirheumatic drugsArthritis Care & Research, 2012
- Infections Associated with Tumor Necrosis Factor‐α AntagonistsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Modulation of Infection with Histoplasma capsulatum by Inhibition of Tumor Necrosis Factor–α ActivityClinical Infectious Diseases, 2005
- Tumor Necrosis Factor Inhibition and Opportunistic InfectionsClinical Infectious Diseases, 2005
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor AntagonistsClinical Infectious Diseases, 2004
- Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting PathologyInfection and Immunity, 2001
- The Immunosuppressive Effects of Dexamethasone Administered in Drinking Water to C57BL/6N Mice Infected with Cryptosporidium parvumJournal of Parasitology, 1993